DEF 14AThe Ballot
Allogene Therapeutics, Inc. files DEF 14A
Filed Apr 30, 2026 · 2mo ago · Accession 0001628280-26-028948
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Allogene Therapeutics, Inc.
- Ticker
- ALLO
- CIK
- 1737287
- Form type
- DEF 14A
- Filing date
- Apr 30, 2026
- Report date
- Jun 18, 2026
- Document
- allo-20260430.htm
- Size
- 5.9 MB